Skip to main content

November 2017

 

 

academics

 

Clinical research courses

Job for Area Business Manager, Senior Manager at Panacea Biotec | B.Pharm, MBA, M.Sc

Panacea Biotec is a leading research based Health Management Company, with an annual turnover of approx. Rs. 830 Crores. We are engaged in research, development, manufacture & marketing of Vaccines, Bio-Pharmaceuticals and Pharmaceuticals (Rx & OTC) of international quality and Health Services. All Panacea Biotec plants are accredited by international agencies and they follow current Good Manufacturing Practices, as per WHO guidelines.We offer stimulating work environment & a career that spells growth. In tune with our plans, we require young, aggressive, dynamic, high performing and result oriented professional.

Post : Sr. Manager/ AGM – Business Development

Recruitment in Cancer Registry at Tata Memorial Centre | 08 posts

The Tata Memorial Centre (TMC) is a Comprehensive Cancer Centre with a mission to achieve the highest standards in patient care, cancer prevention, cancer research and professional development for oncology and allied disciplines. TMC is an autonomous Grant-in-Aid Institute of the Department of Atomic Energy, Government of India. TMC is affiliated to Homi Bhabha National Institute (HBNI). The HBNI is a Deemed University of the Department of Atomic Energy with a mission to develop high quality postgraduate educational programs in science and technology including those related to life and health sciences.

Following post on “Population Based Cancer Registry Varanasi, UP” Project (A/c 3732). Initially for a period of six months.

Career at Frost & Sullivan as Industry Analyst - Transformational Health

Frost & Sullivan, a global growth consulting firm founded in 1961, has 32 offices with more than 1500 industry analysts and consultants world-wide. With an integrated approach to consulting through technology research, market research, economic research, corporate best practices, training, customer research, competitive intelligence and corporate strategy - Frost & Sullivan is one of the world leaders in this space.

Post : Industry Analyst / Senior Industry Analyst - Transformational Health (Digital Health)

REVIEW ON ZIKA VIRUS

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
Nayan Jain*, Ashutosh Biswas, Kratika Vivek Daniel
Mandsaur Institute of pharmacy,

Mandsaur, MP, India
*nayanofficial499@gmail.com

ABSTRACT
Today the world has suffered to the Zika virus is a flavivirous related to yellow fever, dengue, West Nile and Japanese encephalis virus. Zika virus causes acute, serious illness which is often fatal if it is not treated. Its name comes from the Zika forest of Uganda. Zika is a mosquito born disease. Zika virus disease is caused by a virus transmitted primarily by Aedes mosquitoes. People with Zika virus disease can have symptoms including mild fever, skin rash, conjunctivitis, muscle and joint pain, malaise or headache. These symptoms normally last for 2-7 days. There is scientific consensus that Zika virus is a cause of microcephaly and Guillain-Barré syndrome. Links to other neurological complications are also being investigated. Neither an effective treatment nor a vaccine is available for Zika virus; therefore, the public health response primarily focuses on preventing infection, particularly in pregnant women. These article also covers from where the zika was firstly introduced or its history, its transmissions, causes, diagnosis, treatment and some current affairs.

In recent years, the search for new cancer treatments has increasingly focused on immunotherapies that harness the body's own defenses to fight tumors. Adoptive cell therapy (ACT) is a powerful immunotherapeutic strategy that can effectively control some cancers but that also has drawbacks. To administer ACT, T cells are withdrawn from a patient and cultivated in a laboratory (ex vivo) for weeks or months, until a massive number of cells are available to be injected back into the patient. During ex vivo cultivation, the T cells often lose potency and life span.

Celgene Corporation recently announced results from two phase 3 trials evaluating the efficacy and safety of the drug ozanimod. Ozanimod was invented by scientists at The Scripps Research Institute (TSRI). Ozanimod is a novel, oral, selective sphingosine 1-phosphate 1 (S1PR1) and 5 (S1PR5) receptor modulator, and was compared to the first-line treatment, Avonex® (interferon beta-1a) (IFN), in patients with relapsing multiple sclerosis (RMS). The findings from the two pivotal phase 3 (SUNBEAM and RADIANCE Part B) trials pave the way for ozanimod to enter the New Drug Approval process with the U.S. Food and Drug Administration (FDA).

The vaccine that protects against cancer-causing types of human papillomavirus (HPV) also prevents an uncommon but incurable childhood respiratory disease, according to a new study published in The Journal of Infectious Diseases. The findings suggest that the chronic and difficult-to-treat condition, recurrent respiratory papillomatosis, is disappearing in Australian children as a result of the nation’s highly successful HPV vaccination program.

Recruitment for Pharmacists (21 posts) in Central Government Health Scheme

Initially the Ministry of Health and Family Welfare had two Departments, Each of these Departments was headed by the Secretary to the Government of India:-   Department of Health & Family Welfare, Department of Health Research. Now Ministry of Health and Family Welfare comprises the following two departments, each of which is headed by a Secretary to the Government of India:- Directorate General of Health Services (DGHS) is attached office of the Department of Health & Family Welfare and has subordinate offices spread all over the country. The DGHS renders technical advice on all Medical and Public Health matters and is involved in the implementation of various Health Services.